Related references
Note: Only part of the references are listed.High dose genistein aglycone therapy is safe in patients with mucopolysaccharidoses involving the central nervous system
Katherine H. Kim et al.
MOLECULAR GENETICS AND METABOLISM (2013)
Enzyme replacement therapy started at birth improves outcome in difficult-to-treat organs in mucopolysaccharidosis I mice
Guilherme Baldo et al.
MOLECULAR GENETICS AND METABOLISM (2013)
An algorithm to predict phenotypic severity in mucopolysaccharidosis type I in the first month of life
Sandra D. K. Kingma et al.
ORPHANET JOURNAL OF RARE DISEASES (2013)
Anticancer effect of genistein on BG-1 ovarian cancer growth induced by 17 β-estradiol or bisphenol A via the suppression of the crosstalk between estrogen receptor alpha and insulin-like growth factor-1 receptor signaling pathways
Kyung-A Hwang et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
Genistein in Sanfilippo disease: A randomized controlled crossover trial
Jessica de Ruijter et al.
ANNALS OF NEUROLOGY (2012)
Synthetic genistein derivatives as modulators of glycosaminoglycan storage
Anna Kloska et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Bone, joint and tooth development in mucopolysaccharidoses: Relevance to therapeutic options
E. Oussoren et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
The skeleton: a multi-functional complex organ. The growth plate chondrocyte and endochondral ossification
E. J. Mackie et al.
JOURNAL OF ENDOCRINOLOGY (2011)
Orthopaedic management of Hurler's disease after hematopoietic stem cell transplantation: a systematic review
Marleen H. van der Linden et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2011)
Genistein supplementation in patients affected by Sanfilippo disease
Veronica Delgadillo et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2011)
Two-year follow-up of Sanfilippo Disease patients treated with a genistein-rich isoflavone extract: Assessment of effects on cognitive functions and general status of patients
Ewa Piotrowska et al.
MEDICAL SCIENCE MONITOR (2011)
Effects of flavonoids on glycosaminoglycan synthesis: implications for substrate reduction therapy in Sanfilippo disease and other mucopolysaccharidoses
Anna Kloska et al.
METABOLIC BRAIN DISEASE (2011)
Adipogenic, Chondrogenic and Osteogenic Differentiation of Clonally Derived Human Dermal Fibroblasts
Johan P. E. Junker et al.
CELLS TISSUES ORGANS (2010)
Storage correction in cells of patients suffering from mucopolysaccharidoses types IIIA and VII after treatment with genistein and other isoflavones
Audrey Arfi et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2010)
Genistein Improves Neuropathology and Corrects Behaviour in a Mouse Model of Neurodegenerative Metabolic Disease
Marcelina Malinowska et al.
PLOS ONE (2010)
Effects of genistein on secretion of extracellular matrix components and transforming growth factor beta in high-glucose-cultured rat mesangial cells
Wei-Jie Yuan et al.
JOURNAL OF ARTIFICIAL ORGANS (2009)
Toxicity of peroxisomal C27-bile acid intermediates
Sacha Ferdinandusse et al.
MOLECULAR GENETICS AND METABOLISM (2009)
Genistein-mediated inhibition of glycosaminoglycan synthesis, which corrects storage in cells of patients suffering from mucopolysaccharidoses, acts by influencing an epidermal growth factor-dependent pathway
Joanna Jakobkiewicz-Banecka et al.
JOURNAL OF BIOMEDICAL SCIENCE (2009)
Mechanism of glycosaminoglycan-mediated bone and joint disease - Implications for the mucopolysaccharidoses and other connective tissue diseases
Calogera M. Simonaro et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
The clinical outcome of Hurler syndrome after stem cell transplantation
Mieke Aldenboven et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years
Monica Sifuentes et al.
MOLECULAR GENETICS AND METABOLISM (2007)
Genistein-mediated inhibition of glycosaminoglycan synthesis as a basis for gene expression-targeted isoflavone therapy for mucopolysaccharidoses
Ewa Piotrowska et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2006)
Musculoskeletal manifestations of hurler syndrome - Long-term follow-up after bone marrow transplantation
JS Weisstein et al.
JOURNAL OF PEDIATRIC ORTHOPAEDICS (2004)
Bone morphogenetic protein 9:: A potent modulator of cartilage development in vitro
T Blunk et al.
GROWTH FACTORS (2003)
Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data
C Ramakers et al.
NEUROSCIENCE LETTERS (2003)
Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH)
ON Koç et al.
BONE MARROW TRANSPLANTATION (2002)
Bone morphogenetic proteins-2, -12, and -13 modulate in vitro development of engineered cartilage
KJ Gooch et al.
TISSUE ENGINEERING (2002)
Differential effects of growth factors on tissue-engineered cartilage
T Blunk et al.
TISSUE ENGINEERING (2002)
Pharmacokinetics of [14C]Genistein in the rat:: Gender-related differences, potential mechanisms of biological action, and implications for human health
NG Coldham et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2000)
Share Paper
